Latest Articles

Publication Date
Association of endometrial cancer risk with hypertension- an updated meta-analysis of observational studies - Nature.com

Association of endometrial cancer risk with hypertension- an updated meta-analysis of observational studies Nature.com

Published: Oct. 22, 2024, 2:08 p.m.
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer - Physician's Weekly

Pembrolizumab Aids Survival With High-Risk Endometrial Cancer Physician's Weekly

Published: Oct. 22, 2024, 6:31 a.m.
Research progress on correlative prediction factors and prediction models of endometriosis associated ovarian carcinoma.

Endometriosis is a common benign disease in women of childbearing age, with a malignant change rate of about 1%. Endometriosis associated ovarian cancer (EAOC), which usually occurs in the ovaries, …

Published: Oct. 22, 2024, midnight
Rectal mass: cancer or endometriosis?

Published: Oct. 22, 2024, midnight
A nomogram model to predict recurrence of early-onset endometrial cancer after resection based on clinical parameters and immunohistochemical markers: A multi-institutional study - Frontiers

A nomogram model to predict recurrence of early-onset endometrial cancer after resection based on clinical parameters and immunohistochemical markers: A multi-institutional study Frontiers

Published: Oct. 21, 2024, 6:48 p.m.
How itching 'down there' could be sign of rare cancer & other signs to watch for - The Sun

How itching 'down there' could be sign of rare cancer & other signs to watch for The Sun

Published: Oct. 21, 2024, 6:30 p.m.
Pembrolizumab aids survival with high-risk endometrial cancer - Medical Xpress

Pembrolizumab aids survival with high-risk endometrial cancer Medical Xpress

Published: Oct. 21, 2024, 5:50 p.m.
Markman’s Take: Vibostolimab in dMMR Endometrial Cancer, Adjuvant Chemo in Cervical Cancer, and More - OncLive

Markman’s Take: Vibostolimab in dMMR Endometrial Cancer, Adjuvant Chemo in Cervical Cancer, and More OncLive

Published: Oct. 21, 2024, 5:04 p.m.
Pembrolizumab Aids Survival With High-Risk Endometrial Cancer - HealthDay

Pembrolizumab Aids Survival With High-Risk Endometrial Cancer HealthDay

Published: Oct. 21, 2024, 3:35 p.m.
Apigenin as a Promising Agent for Enhancing Female Reproductive Function and Treating Associated Disorders.

Apigenin is an organic flavonoid abundant in some plants such as parsley, chamomile, or celery. Recently, it has been investigated for several of its pharmacological characteristics, such as its ability …

Published: Oct. 21, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!